A8801007 A Phase I, Healthy Volunteer Qualification Of Ligand [C 11] PF 04621053 And Randomized Determination Of H3 Receptor Occupancy Of PF 03654746, Using PET.

Trial Profile

A8801007 A Phase I, Healthy Volunteer Qualification Of Ligand [C 11] PF 04621053 And Randomized Determination Of H3 Receptor Occupancy Of PF 03654746, Using PET.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2008

At a glance

  • Drugs PF 3654746 (Primary)
  • Indications Cognition disorders
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 02 Dec 2008 Actual patient number (10) added as reported by ClinicalTrials.gov.
    • 02 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top